The United States Pharmacopeial Convention

Based in MD

🤖

AI Overview

With $2.6M in lobbying spend across 32 quarterly filings, The United States Pharmacopeial Convention is a significant lobbying presence. Their lobbying covers 4 issue areas. Active from 2018 to 2025.

$2.6M
Total Spend
8
Years Active
1
Firms Hired
3
Lobbyists Deployed
4
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2018$270K
2019$450K
2020$420K
2021$370K
2022$320K
2023$220K
2024$240K
2025$360K

Issues Lobbied

Lobbying Firms

Lobbyists

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Pharmacy, Health Issues, Budget/Appropriations, Defense

  • S.2315, Over-the-Counter Drug Safety, Innovation, and Reform Act;
  • Over-the-counter reform;
  • Role of USP monographs in FDAs OTC monograph system;
  • FDA appropriations; role of quality standards;
  • The
  • H.R. 5687, SOUND Disposal and Packaging Act; provisions related to FDA packaging and disposal.
  • FDA appropriations; role of quality standards;
  • USP work on opioids;
  • HR 6, SUPPORT for Patients and Communities Act; provisions related to opioids.
  • Potential role of compendial standards for packaging
  • HR 1959, To amend the Federal Food, Drug, and Cosmetic Act with respect to compounding pharmacies, and for other purposes; all provisions
  • 2020 Budget, specifically provisions related to encouraging Biosimilar Development

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.